Metraipolis › archive › dc_d9a4f32dc014

Testosterone supplementation improves insulin responsiveness in HFD fed male T2DM mice and potentiates insulin signaling in the skeletal muscle and C2C12… — Europe PMC PMID:31693697

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31693697
DOI
10.1371/journal.pone.0224162
License (as archived)
CC0-1.0
Archived
2026-11-10T04:15:45.178Z
SHA-256 of the archived text
a133ebc78235effa5f1c8ca68534edf90eb5b024ea6cb35b2e6143708e1591c3
Stable URL of this page
https://metraipolis.com/documento/dc_d9a4f32dc014

How to cite

Testosterone supplementation improves insulin responsiveness in HFD fed male T2DM mice and potentiates insulin signaling in the skeletal muscle and C2C12… — Europe PMC PMID:31693697 — Europe PMC (en), https://europepmc.org/article/MED/31693697 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d9a4f32dc014 (Metraipolis archive dc_d9a4f32dc014, sha256 a133ebc78235effa5f1c8ca68534edf90eb5b024ea6cb35b2e6143708e1591c3)
BibTeX
@misc{dcd9a4f32dc014,
  title = {Testosterone supplementation improves insulin responsiveness in HFD fed male T2DM mice and potentiates insulin signaling in the skeletal muscle and C2C12… — Europe PMC PMID:31693697},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31693697},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d9a4f32dc014; sha256 a133ebc78235effa5f1c8ca68534edf90eb5b024ea6cb35b2e6143708e1591c3},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31693697. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Type 2 Diabetes Mellitus (T2DM) is characterised by hyperglycemia due to the incidence of insulin resistance. Testosterone supplementation has been shown to have a positive co-relation with improved glycemic control in T2DM males. Clinical studies have reported that Androgen Replacement Therapy (ART) to hypogonadic males with T2DM resulted in improved glycemic control and metabolic parameters, but, these studies did not address in detail how testosterone acted on the key glucose homeostatic organs. Method: In this study, we delineate the effect of testosterone supplementation to high-fat diet (HFD) induced T2DM in male C57BL6J mice and the effect of testosterone supplementation on the skeletal muscle insulin responsiveness. We also studied the effect of testosterone on the insulin signaling pathway proteins in C2C12 myocyte cells to validate the in vivo findings. Results: We found that testosterone had a potentiating effect on the skeletal muscle insulin signaling pathway to improve glycaemic control. We demonstrate that, in males, testosterone improves skeletal muscle insulin responsiveness by potentiating the PI3K-AKT pathway. The testosterone treated animals showed significant increase in the skeletal muscle Insulin Receptor (IR), p85 subunit of PI3K, P-GSK3α (Ser-21), and P-AKT (Ser-473) levels as compared to the control animals; but there was no significant change in total AKT and GSK3α. Testosterone supplementation inhibited GSK3α in the myocytes in a PI3K/AKT pathway dependent manner; on the other hand GSK3β gene expression was reduced in the skeletal muscle upon testosterone supplementation. Conclusion: Testosterone increases insulin responsiveness by potentiating insulin signaling in the skeletal muscle cells, which is in contrast to the increased insulin resistance in the liver of testosterone treated T2DM male animals.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2019 (prima pubblicazione 2019-11-06).
Identificativi: PMID 31693697 · PMCID PMC6834245 · DOI 10.1371/journal.pone.0224162.
Descrittori MeSH principali: Insulin Resistance.
Pagina: https://europepmc.org/article/MED/31693697 — https://doi.org/10.1371/journal.pone.0224162. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-10T04:13:26.813Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.